Johnson & Johnson Medical Devices Companies is collaborating with Charleston-based Medical University of South Carolina to mitigate the risk of infection for patients in its operating room and ambulatory surgery facilities.
MUSC will leverage J&J's CareAdvantage platform, which aims to reduce infection risk by offering a data-driven approach to help hospitals and health systems. The platform features an infection risk management capability that focuses on risk factors of costly infections as well as clinical practice patterns that can lead to the proliferation of hospital-acquired infections.
The capability also offers evidence-based practices to reduce the risk factors of HAIs, including bloodstream infections and surgical site infections.
"Through its evidence-based approach, JJMDC is helping us to identify and address our needs specific to infection risk management, including appropriate techniques for its products, and provide training and education resources for our care team members. Our common goal is providing the highest level of patient care possible," said Danielle Scheurer, MD, chief quality officer, hospitalist and associate professor of medicine at MUSC.
More articles on quality:
Depression affects nearly one-third of hospital patients, study finds
AHA urges CMS: Use only quality measures that matter
61% of pediatric nurses in poor work environments miss care, study shows